类风湿性关节炎:合成剂的发病,治疗策略,进展和结构性活动关系
Bisma Jan1, Khursheed Ahmad Sheikh2, Shazia Javeed1
1Pharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar- 190006, Jammu and Kashmir, India.
Current topics in medicinal chemistry
|April 15, 2025
概括
风湿性关节炎 (RA) 管理正在推进,新的药物标如BTK和JAK抑制剂. 本综述探讨了新兴疗法,它们的机制以及RA治疗的未来方向.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 类风湿病学 类风湿病学
背景情况:
- 类风湿性关节炎 (RA) 是一种普遍存在的炎症性关节炎,会影响膜.
- 现有的RA疗法面临的局限性包括副作用和治疗耐药性,需要新药.
研究的目的:
- 提供有关类风湿性关节炎 (RA) 的全面概述.
- 详细介绍针对RA病变的新兴药理干预措施.
- 检查RA药物发现的挑战和未来方向.
主要方法:
- 审查有关RA病理生理学,诊断和治疗的当前文献.
- 分析结构-活性关系 (SAR) 和新药候选者的机制.
- 批判性地检查RA药物开发的创新湿实验室方法.
主要成果:
- 包括BTK,JAK,TLR4,COX-2和LOX抑制剂在内的新兴药物类显示出有前途.
- 了解RA病变发生的特定分子途径正在进步.
- 正在开发新的治疗策略,以克服当前治疗的局限性.
结论:
- 针对特定途径的新型抑制剂为改善RA管理提供了潜力.
- 对SAR和机制的进一步研究对于优化药物疗效至关重要.
- 需要创新的方法来解决RA治疗的未满足需求.
相关概念视频
The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K
Structure-Activity Relationships and Drug Design
450
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
450
Genome-wide Association Studies-GWAS
12.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.1K
T Cell Types and Functions
633
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
633
Combined Effects of Drugs: Antagonism
8.1K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.1K
Principles of Drug Action
5.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.6K


